
Precision Meets Innovation in TAVR Procedures
Our SavvyWire is a groundbreaking solution designed to enhance the efficiency and accuracy of Transcatheter Aortic Valve Replacement (TAVR) procedures. As the first-of-its-kind sensor-guided pressure wire, SavvyWire combines multiple functions into a single device, streamlining workflow and enhancing patient outcomes.
Why choose SavvyWire?
-
Three-in-One Functionality
The SavvyWire uniquely combines pacing, pressure monitoring, and wire support, enabling seamless transitions throughout TAVR procedures. By eliminating the need to switch between devices, SavvyWire reduces procedural complexity and enhances efficiency.
-
Advanced Sensor-Guided Technology
Equipped with advanced pressure sensor technology, SavvyWire provides accurate, real-time measurements for precise positioning and control. This real-time data empowers clinicians to make informed decisions quickly, leading to improved patient safety and procedural success.
-
Optimized Workflow
The SavvyWire is designed to support both valve delivery and post-deployment hemodynamic assessment, ensuring smooth, uninterrupted procedures. With its unique features, it simplifies the TAVR process, helping clinical teams save time and resources.
-
Enhanced Patient Safety
SavvyWire minimizes the risk of complications, such as bleeding and infections, providing a safer experience for patients undergoing TAVR procedures by reducing the number of device changes.
Key Features of the SavvyWire
- Real-time pressure monitoring for accurate positioning and patient safety
- Integrated pacing capabilities, reducing the need for additional devices
- Durable design for reliable support during valve delivery
- Optimized to improve workflow efficiency in TAVR procedures
Who Can Benefit from SavvyWire?
New Clinical Data Underscores the Prognostic Value of Invasive Gradients
A recent single-center study (van den Dorpel et al., EuroIntervention 2025) has established a direct link between post-TAVI invasive mean pressure gradients (iMPG) and mortality outcomes – with important implications for real-time decision-making during procedures.
🔹 iMPG >10 mmHg is a clinically significant threshold for predicting increased mortality after TAVI.
🔹 Invasive pressure gradients (not echocardiography) were strongly correlated with mortality at 30 days, 1 year, and 2 years.
🔹 Echocardiography consistently overestimated gradients, especially in balloon-expandable valves (BEV), highlighting the need for real-time invasive measurement.
Explore the Future of TAVR with SavvyWire

Lorem ipsum dolor amet prism banjo beard brooklyn vaporware vexillologist. Swag cardigan PBR&B affogato, health goth vice.
Sanda Cambel
Director of Marketing

Lorem ipsum dolor amet prism banjo beard brooklyn vaporware vexillologist. Swag cardigan PBR&B affogato, health goth vice.
Sanda Cambel
Director of Marketing

Lorem ipsum dolor amet prism banjo beard brooklyn vaporware vexillologist. Swag cardigan PBR&B affogato, health goth vice.